Silencing of the TFPI-2 gene associated with hypermethylation of the promoter has recently been described in several cancer cell lines derived from choriocarcinoma (Hube et al, 2003b), glioma (Konduri et al, 2003), fibrosarcoma, breast and prostate cancers (Rao et al, 2003). The gene discussed is TFPI2; the disease is glioma.